FDA defends oversight amid questions of safety of generic drugs made in India and China

0
13
This post was originally published on this site
https://www.gannett-cdn.com/presto/2019/05/17/USAT/49e446d5-ae1f-4714-a433-786753db9b6b-B03_MONEYLINE_Ranbaxy_14.JPG

The FDA defends its track records of inspections of overseas drug factories as a new book raises question about the safety of generic drugs